HRT decreases DNA and lipid oxidation in postmenopausal women

References

• Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot (Lond) 2003;91:179–94
   PubMed Web of Science ®Google Scholar
• Scandalios JG. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defensas. Braz J Med Res 2005;38:995–1014
   PubMed Web of Science ®Google Scholar
• Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176–86
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC, eds. Antioxidant defenses. In Free Radicals in Biology and Medicine, 3rd edn. New York: Oxford University Press, 1998
   Google Scholar
• Willcox J, Ash S, Catignani G. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44:275–95
   PubMed Web of Science ®Google Scholar
• Tribble DL, Frank E. Dietary antioxidants, cancer and atherosclerotic heart disease. West J Med 1994;161:605–12
   PubMedGoogle Scholar
• Ortiz A, Vargas R, Muñoz G. Incidencia y mortalidad del cáncer en Costa Rica. Costa Rica: Kamelot Comunicación y Arte, 2005
   Google Scholar
• Stocker R, Keaney J. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381–478
   PubMed Web of Science ®Google Scholar
• Heinecke J. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141:1–15
   PubMed Web of Science ®Google Scholar
• Salonen T, Yla-Herttulal S, Yamamoto R. Autoantibodies against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883–7
   PubMed Web of Science ®Google Scholar
• Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. ACJN 1991;53:326–34S
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Hennekens CH, Manson J, Colditz G, Rosner B, Willett W. Vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993;328:1444–9
   PubMed Web of Science ®Google Scholar
• Stephens NG, Parsons A, Schofield PM, . Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781–6
   PubMed Web of Science ®Google Scholar
• Yusuf S. Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 2000;354:1917–18
   Google Scholar
• Ebell MH. Efficacy of antioxidants in GI cancer prevention. Am Fam Physician 2005;71:465–6
   PubMed Web of Science ®Google Scholar
• Salaganik RL. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001;20(Suppl):464–75S
   Google Scholar
• Lamson DW, Brignall MS. Antioxidants and cancer. 3. Quercetin. Altern Med Rev 2000;5:304–29
   Google Scholar
• Christen Y. Oxidative stress in Alzheimer's disease. Am J Clin Nutr 2000;71:621–9S
   PubMed Web of Science ®Google Scholar
• Smith MA, Perry G, Richery PL. Oxidative damage in Alzheimer's disease. Nature 1996;382:120–1
   PubMed Web of Science ®Google Scholar
• Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age related cataract and vision loss: AREDS report no.9. Arch Ophthalmol 2001; 119:1439–52
   PubMed Web of Science ®Google Scholar
• Ehret A, Westendorp MO, Herr I, . Resistance of chimpanzee T cells to human virus type 1 Tat-enhanced oxidative stress and apoptosis. J Virol 1996;70:6502–7
   PubMed Web of Science ®Google Scholar
• Strehlow K, Rotter S, Wassmann S, . Modulation of antioxidant lipid expression and function by estrogen. Circ Res 2003; 93:170–7
   PubMed Web of Science ®Google Scholar
• Unfer T, Conterato M, da Silva J, Duarte M, Emanuelli T. Influence of hormonal replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chem Acta 2006;369:73–7
   PubMed Web of Science ®Google Scholar
• Signorelli S, Neri S, Sciacchitano S, DiPino L, Costa M, Marchese G. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006;53:77–82
   PubMed Web of Science ®Google Scholar
• Lippert TH, Seeger H, Mueck A. Clinical and pharmacological characteristics of the conjugated equine estrogens. Is their use in postmenopausal hormone replacement therapy still up to date? Arnzneimitteltherapie 1999;17:362–4
   Google Scholar
• O’Connell MB. Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol 1995;35 (Suppl):18–24S
   Google Scholar
• Bhavanani BR. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med 1998;217:6–16
   PubMed Web of Science ®Google Scholar
• Lippert TH, Seeger H, Mueck A. Pharmocodynamics and toxicology of different estrogens. Hormone replacement in postmenopausal women: are all estrogens equal? Gynecol Endocrinol 2001;15:26–33
   Google Scholar
• Ayres S, Abplanalp W, Liu J, Ravi T. Mechanisms involved in the protective effect of estradiol-17β on lipid peroxidation and DNA damage. Am J Physiol 199;274:E1002–8
   Google Scholar
• Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77:1095–7
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Yanase T, Kobayashi K, . Catechol estrogens are more potent antioxidants than estrogens for the Cu(2 +) catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins. Endocr J 1994;41: 605–11
   PubMed Web of Science ®Google Scholar
• Ke R, Todd D, Ahokas R. Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil Steril 2003;79: 1118–22
   PubMed Web of Science ®Google Scholar
• Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, . Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocinol 2004;19:57–63
   PubMed Web of Science ®Google Scholar
• Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett 1987;213:9–14
   PubMed Web of Science ®Google Scholar
• Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Molec Biol 1998;108:101–6
   PubMedGoogle Scholar
• Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol 1994;366:43–58
   PubMedGoogle Scholar
• Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991;266:2005–8
   PubMed Web of Science ®Google Scholar
• Kampa M, Nistikaki A, Tsaousis V. A new automated method for the determination of the total antioxidant capacity (TAC) of human plasma, based on the crocin bleaching assay. BMC Clin Pathol 2002;2:3–18
   PubMedGoogle Scholar
• Beckman KB, Arnes B. Oxidative decay of DNA. J Biol Chem 1997;272:19633–6
   PubMed Web of Science ®Google Scholar
• Espeland M, Hogan P, Fineberg S, . Effects of postmenopausal therapy on glucose and insulin concentration. Diabetes Care 1998;21:189–95
   Web of Science ®Google Scholar
• Kanaya A, Herrington D, Vittinghoff E, . Glycemic effects of postmenopausal hormone therapy: The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2003;138:1–9
   PubMed Web of Science ®Google Scholar
• Liu S, Le May C, Wong MP, . Importance of extranuclear estrogen receptor and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 2009;58:22902–302
   Web of Science ®Google Scholar
• Friday K, Dong C, Fontenot R. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 2001;86:48–52
   PubMed Web of Science ®Google Scholar
• Lamon-Fava S, Herrington DM, Horvath KV, Schaefer EJ, Asztalos BF. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism 2010;59:1794–800
   PubMed Web of Science ®Google Scholar
• Lamon-Fava S, Herrington DM, Reboussin DM, . Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis 2009;205:325–30
   PubMed Web of Science ®Google Scholar
• Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer E. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins. Metabolism 2003;52:1330–6
   PubMed Web of Science ®Google Scholar
• Arteaga E, Rojas A, Villaseca P, Bianchi M, Arteaga A, Duran D. In vitro effect of estradiol, progesterone, testosterone and of combined estradiol/progestins on low density lipoprotein oxidation in postmenopausal women. Menopause 1998;5:16–23
   PubMed Web of Science ®Google Scholar
• Ozden S, Dildar K, Hakan Y, Guilzar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 2001;38:165–70
   PubMed Web of Science ®Google Scholar
• Wen Y, Doyle M, Norris L, . Combined oestrogen- progesterone replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol 1999;47:315–21
   PubMed Web of Science ®Google Scholar
• Naziroglu M, Simsek M, Simsek H, Aydilek N, Ozcan Z, Artilgan R. The effects of hormone replacement therapy combined with vitamins C and E on antioxidant levels and lipid profiles in postmenopausal women with type 2 diabetes. Clin Chim Acta 2004;344:63–71
   PubMed Web of Science ®Google Scholar
• Wassmann K, Wassmann S, Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 2005;97:1046–54
   PubMed Web of Science ®Google Scholar
• Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005;36:172–6
   Web of Science ®Google Scholar